MedPath

HMB Supplementation in Addition to Multicomponent Exercise in Old Adults

Not Applicable
Completed
Conditions
Aging
Frail Elderly Syndrome
Physical Activity
Interventions
Other: Multicomponent physical exercise program
Dietary Supplement: HMB dietary supplementation
Registration Number
NCT03827499
Lead Sponsor
Universidad de Murcia
Brief Summary

Evidence supports the fact that multicomponent exercise and β-hydroxy-β-methylbutyrate (HMB) supplementation are, separately, effective in improving old adult's health and palliate functional metabolic diseases in the elderly. However, the true effect of HMB supplementation combined with a tailored exercise program in frail old adults is still unknown. Thus, the aim of the HEAL study is to assess the effects of the combination of a daily multicomponent exercise and resistance training intervention in addition to HMB supplementation on old adults' health.

Detailed Description

Evidence supports the fact that multicomponent exercise and β-hydroxy-β-methylbutyrate (HMB) supplementation are, separately, effective in improving old adult's health and palliate functional metabolic diseases in the elderly. However, the true effect of HMB supplementation combined with a tailored exercise program in frail old adults is still unknown.

Thus, the aim of the HEAL study is to assess the effects of the combination of a daily multicomponent exercise and resistance training intervention in addition to HMB supplementation on old adults' health.

The findings of the HEAL study will help professionals from public health systems to identify cost-effectiveness and innovative actions to improve older people's health and quality of life, and endorse exercise practice in older adults living in nursing homes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  • Men and women aged ≥70 years living in a nursing home
  • Be able to follow an active physical rehabilitation program
  • Be able to read and wright
  • Voluntary participation
  • Capable and willing to provide an informed consent
Exclusion Criteria
  • Acute heart attack (recent 3-6 months) or unstable angina
  • Uncontrolled atrial or ventricular arrhythmias
  • Aortic dissecting aneurysm
  • Severe aortic stenosis
  • Acute endocarditis / pericarditis
  • Uncontrolled high blood pressure (>180/100 mmHg)
  • Acute thromboembolism
  • Acute or severe heart failure
  • Acute or severe respiratory failure
  • Uncontrolled postural hypotension
  • Uncontrolled acute decompensated diabetes mellitus or low blood sugar
  • A recent fracture in the last month.
  • Coincident participation in any intervention trial
  • HMB contraindication, intolerance, or allergy
  • Community-dwelling people
  • Have regularly performed exercise (>20 minutes >3 days/week) in the last 3 months
  • Malignant diseases (exceptions: basal or squamous-cell skin carcinoma or carcinoma in situ of the uterine cervix)
  • Revascularization within 1 year
  • Severe loss of vision, hearing, or communicative ability
  • Conditions preventing cooperation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ex-PlacMulticomponent physical exercise programMulticomponent physical exercise program
Ex-HMBHMB dietary supplementationHMB dietary supplementation and Multicomponent physical exercise program
Ex-HMBMulticomponent physical exercise programHMB dietary supplementation and Multicomponent physical exercise program
NoEx-HMBHMB dietary supplementationHMB Dietary supplementation
Primary Outcome Measures
NameTimeMethod
Change in physical functional performance based on the Short Physical Performance Battery (SPPB) scoreBaseline to 25 Weeks

Summary scores range from 0-12 and higher scores denote higher physical performance.

Secondary Outcome Measures
NameTimeMethod
Change in Disability (Lawton index scores)Baseline to 25 Weeks

Disability in instrumental activities of daily living.

Change in upper-body strength (kg)Baseline to 25 Weeks

Vertical bench press one-repetition maximun test

Change in glycaemic profileBaseline to Week 25

Plasma glucose, insulin and glycosylated haemoglobin (all in mg/dL)

Change in frailty (score)Baseline to 25 Weeks

Frailty phenotype determination using Fried's criteria

Change in Handgrip strength (kg)Baseline to 25 Weeks

Using a dynamometer

Change in Comorbidity (score)Baseline to 25 Weeks

When a participant presents two or more geriatric syndromes from a list of selected geriatric syndromes

Change in cognitive function (score)Baseline to 25 Weeks

Using the Mini-Mental State Examination

Change in lower-body strength (kg)Baseline to 25 Weeks

Seated leg press one-repetition maximun test

Change in upper-body strength power output (m/s)Baseline to 25 Weeks

Vertical bench press load-velocity profile

Change in lipid profileBaseline to Week 25

Plasma total, high-density lipoprotein and low-density lipoprotein cholesterol and triglycerides (all in mg/dL)

Change in Thyroid-Stimulating Hormone (mIU/L)Baseline to Week 25
Change in lower-body strength power output (m/s)Baseline to 25 Weeks

Seated leg press load-velocity profile

Change in lean body mass (kg)Baseline to Week 25

Change in lean body mass using dual energy x-ray absorptiometry

Change in Disability (Barthel index scores)Baseline to 25 Weeks

Disability in basic activities of daily living

Change in depression (score)Baseline to 25 Weeks

Using the 15-item Yesavage geriatric depression

Trial Locations

Locations (1)

Faculty of Sport Sciences

🇪🇸

Murcia, San Javier, Spain

© Copyright 2025. All Rights Reserved by MedPath